An introduction to metabolomics and its potential application in veterinary science

Comparative Medicine

Volumn 57, Issue 5, 2007, Pages 436-442

  Jones, Oliver A H ^a   Cheung, Victoria L ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VETERINARY DRUG;

DATA ANALYSIS; GAS CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PATTERN RECOGNITION; REVIEW; VETERINARY MEDICINE; ANIMAL; ANIMAL DISEASE; ARTICLE; MASS FRAGMENTOGRAPHY; METABOLISM; METHODOLOGY;

ANIMAL DISEASES; ANIMALS; CHROMATOGRAPHY, LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; METABOLISM; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; VETERINARY MEDICINE;

EID: 38449092866     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. 1H NMR spectroscopy and mass spectrometry-based metabolomic study of the PPAR-α null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. Physiol Genomics 27:178-186.
2. 1H NMR spectroscopy of urine and pattern recognition. Anal Biochem 295:194-202.
3. 1H NMR spectroscopy. FEBS Lett 553:73-78.
4. Breitling R, Pitt AR, Barrett MP. 2006. Precision mapping of the metabolome. Trends Biotechnol 24:543-548.
5. 1H-NMR-based metabonomics. Nature Med 8:1439-1445.
6. Bundy JG, Willey TL, Castell RS, Ellar DJ, Brindle KM. 2005. Discrimination of pathogenic clinical isolates and laboratory strains of Bacillus cereus by NMR-based metabolomic profiling. FEMS Lett 242:127-136.
7. 1H NMR based urine metabolic profiles of male Wistar Han rats: implications for biomarker discovery. Biomarkers 9:156-179.
8. 1H NMR spectra. Phytochemistry 62:1009-1017.
9. Defernez M, Wilson RH. 1997. Infrared spectroscopy: instrumental factors affecting the long-term validity of chemometric models. Anal Chem 69:1288-1294.
10. Deng C, Zhang X, Li N. 2004. Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry. J Chromatogr B 808:269-277.
11. Denkert C, Budczies J, Kind T, Weichert W, Tablack P, Sehouli J, Niesporek S, Konsgen D, Dietel M, Fiehn O. 2006. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res 66:10795-10804.
12. Dunn WB, Bailey NJ, Johnson HE. 2005. Measuring the metabolome: current analytical technologies. Analyst 130:606-625.
13. Dunn WB, Ellis DI. 2005. Metabolomics: current analytical platforms and methodologies. Trends Anal Chem 24:285-294.
14. Ellis DI, Goodacre R. 2006. Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and raman spectroscopy. Analyst 131:875-885.
15. Eriksson L, Johansson E, Kettaneh-Wold N, Wold S. Introduction to multi- and megavariate data analsis using projection methods (PCA and PLS). Umeå (Sweden): Umetrics. p 69-111.
16. Gavaghan McKee CL, Wilson ID, Nicholson JK. 2006. Metabolic phenotyping of nude and normal (Alpk:ApfCD, C57BL10J) mice. J Proteome Res 5:378-384.
17. Goodacre R. 2005. Making sense of the metabolome using evolutionary computation: seeing the wood with the trees. J Exp Bot 56:245-254.
18. Griffin JL. 2004. The potential of metabonomics in drug safety and toxicology. Drug Discov Today Technol 1:285-293.
19. Griffin JL. 2006. Understanding mouse models of disease through metabolomics. Curr Opin Chem Biol 10:309-315.
20. 1H NMR spectroscopy using a 1 mm microlitre probe. Analyst 127:582-584.
21. Griffin JL, Shockcor JP. 2004. Metabolic profiles of cancer cells. Nat Rev Cancer 4:551-561.
22. Griffin JL, Walker LA, Troke J, Osborn D, Shore RF, Nicholson JK. 2000. The initial pathogenesis of cadmium induced renal toxicity. FEBS Lett 478:147-150.
23. Griffiths JR, McSheehy PMJ, Robinson SP, Troy H, Chung Y-L, Leek RD, Williams KJ, Stratford IJ, Harris AL, Stubbs M. 2002. Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1β (HIF-1β): evidence of an anabolic role for the HIF-1 pathway. Cancer Res 62:688-695.
24. Gronquist M, Meinwald J, Eisner T, Schroeder FC. 2005. Exploring uncharted terrain in nature's structure space using capillary NMR spectroscopy: 13 steroids from 50 fireflies. J Am Chem Soc 127:10810-10811.
25. Guhad F. 2005. Introduction to the 3Rs (refinement, reduction, and replacement). Contemp Top Lab Anim Sci 44:58-59.
26. Halouska S, Powers R. 2006. Negative impact of noise on the principal component analysis of NMR data. J Mag Res 178:88-95.
27. Harrigan GG, LaPlante RH, Cosma GN, Cockerell G, Goodacre R, Maddox JF, Luyendyk JP, Ganey PE, Roth RA. 2004. Application of high-throughput Fourier-transform infrared spectroscopy in toxicology studies: contribution to a study on the development of an animal model for idiosyncratic toxicity. Toxicol Lett 146:197-205.
28. Jones GLAH, Sang E, Goddard C, Mortishire-Smith RJ, Sweatman BC, Haselden JN, Davies K, Grace AA, Clarke K, Griffin JL. 2005. A functional analysis of mouse models of cardiac disease through metabolic profiling. J Biol Chem 280:7530-7539.
29. Kaderbhai NN, Broadhurst DI, Ellis DI, Goodacre R, Kell DB. 2003. Functional genomics via metabolic footprinting: monitoring metabolite secretion by Escherichia coli tryptophan metabolism mutants using FT-IR and direct injection electrospray mass spectrometry. Compar Func Genom 4:376-391.
30. Keeler J. 2005. Understanding NMR spectroscopy. Chichester (UK): John Wiley and Sons.
31. Kell DB. 2005. Metabolomics, machine learning and modelling: towards an understanding of the language of cells. Biochem Soc Trans 33:520-524.
32. Keun HC. 2006. Metabonomic modeling of drug toxicity. Pharmacol Therapeut 109:92-106.
33. Kirschenlohr HL, Griffin JL, Clarke SC, Rhydwen R, Grace AA, Schofield PM, Brindle KM, Metcalfe JC. 2006. Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nat Med 12:705-710.
34. Kristal BS, Shurubor YI, Kaddurah-Daouk R, Matson WR. High performance liquid chromatography separations coupled with coulometric electrode array detectors: a unique approach to metabolomics. In: Weckwerth W, editor. Metabolomics methods and protocols (methods in molecular biology). Totowa (NJ): Humana Press. p 159-174.
35. 1H-NMR spectroscopy. NMR Biomed 15:37-44.
36. Levery SB. Glycosphingolipid structural analysis and glycosphingolipidomics. In: Burlingame AL, editor. Methods in enzymology: mass spectrometry: modified proteins and glycoconjugates. Burlington (MA): Academic Press. p 300-369.
37. Lindon JC, Holmes E, Nicholson JK. 2006. Metabonomics techniques and applications to pharmaceutical research & development. Pharmacol Res 23:1075-1088.
38. Nicholson JK, Connelly J, Lindon JC, Holmes E. 2002. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1:153-161.
39. Oliver SG. 2002. Functional genomics: lessons from yeast. Phil Trans R Soc B 357:17-23.
40. Pears MR. 2006. Metabolomic investigation of the neuronal ceroid lipofuscinoses [thesis]. Cambridge (UK): University of Cambridge Department of Biochemistry.
41. 1H NMR based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of batten disease. J Biol Chem 280:42508-42514.
42. Pham-Tuan H, Kaskavelis L, Daykin CA, Janssen H-G. 2003. Method development in high-performance liquid chromatography for high-throughput profiling and metabonomic studies of biofluid samples. J Chromatogr B 789:283-301.
43. Plumb R, Granger J, Stumpf C, Wilson ID, Evans JA, Lenz EM. 2003. Metabonomic analysis of mouse urine by liquid chromatography-time of flight mass spectrometry (LC-TOFMS): detection of strain, diurnal and gender differences. Analyst 128:819-823.
44. Plumb RS, Stumpf CL, Gorenstein MV, Castro-Perez JM, Dear GJ, Anthony M, Sweatman BC, Connor SC, Haselden JN. 2002. Metabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. Rapid Commun Mass Spectrom 16:1991-1996.
45. Robertson DG. 2005. Metabonomics in toxicology: a review. Toxicol Sci 85:809-822.
46. Robertson DG, Reily MD, Baker JD. 2005. Metabonomics in preclinical drug development. Expert Opin Drug Metab Toxicol 1:363-376.
47. Robosky LC, Robertson DG, Baker JD, Rane S, Reily MD. 2002. In vivo toxicity screening programs using metabonomics. Combi Chem High Throughput Screening 5:651-662.
48. Rosenblum ES, Tjeerdema RS, Viant MR. 2006. Effects of temperature on host-pathogen-drug interactions in red abalone, Haliotis rufescens, determined by 1H NMR metabolomics. Environ Sci Technol 40:7077-7084.
49. Schauer N, Fernie AR. 2006. Plant metabolomics: towards biological function and mechanism. Trends Plant Sci 11:508-516.
50. Scheirs J, De Coen A, Covaci A, Beernaert J, Kayawe VM, Caturla M, De Wolf H, Baert P, Van Oostveldt P, Verhagen R, Blust R, De Coen W. 2006. Geneotoxicity in wood mice (Apodemus sylvaticus) along a pollution gradient: exposure-, age-, and gender-related effects. Environ Toxicol Chem 25:2154-2162.
51. Shellie RA, Welthagen W, Zrostlikova J, Spranger J, Ristow M, Fiehn O, Zimmermann R. 2005. Statistical methods for comparing comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry results: metabolomic analysis of mouse tissue extracts. J Chromatogr A 1086:83-90.
52. Soga T, Baran R, Suematsu M, Ueno Y, Ikeda S, Sakurakawa T, Kakazu Y, Ishikawa T, Robert M, Nishioka T, Tomita M. 2006. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem 281:16768-16776.
53. Stanley EG, Bailey NJC, Bollard ME, Haselden JN, Waterfield CJ, Holmes E, Nicholson JK. 2005. Sexual dimorphism in urinary metabolite profiles of Han Wistar rats revealed by nuclear-magnetic-resonance-based metabonomics. Anal Biochem 343:195-202.
54. Stella C, Beckwith-Hall B, Cloarec O, Holmes E, Lindon JC, Powell J, vanderOuderaa F, Bingham S, Cross AJ, Nicholson JK. 2006. Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res 5:2780-2788.
55. Stentiford GD, Viant MR, Ward DG, Johnson PJ, Martin A, Wenbin W, Cooper HJ, Lyons BP, Feist SW. 2005. Liver tumors in wild flatfish: a histopathological, proteomic, and metabolomic study. Omics 9:281-299.
56. Sweetlove LJ, Last RL, Fernie AR. 2003. Predictive metabolic engineering: a goal for systems biology. Plant Physiol 132:420-425.
57. Viant MR. 2003. Improved methods for the acquisition and interpretation of NMR metabolomic data. Biochem Biophys Res Comm 310:943-948.
58. Viant MR, Pincetich CA, Walton JH, Tjeerdema RS, Hinton DE. 2002. Utilizing in vivo nuclear magnetic resonance spectroscopy to study sublethal stress in aquatic organisms. Mar Environ Res 54:553-557.
59. Viant MR, Rosenblum ES, Tjeerdema RS. 2003. NMR-based metabolomics: a powerful approach for characterizing the effects of environmental stressors on organism health. Environ Sci Technol 37:4982-4989.
60. Wang Y, Holmes E, Nicholson JK, Cloarec O, Chollet J, Tanner M, Singer BH, Utzinger J. 2004. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc Natl Acad Sci U S A 101:12676-12681.
61. Whitfield PD, German AJ, Noble PJ. 2004. Metabolomics: an emerging post-genomic tool for nutrition. Br J Nutr 92:549-555.
62. Whitfield PD, Noble P-J, Major H, Beynon RJ, Burrow R, Freeman AL, German A. 2005. Metabolomics as a diagnostic tool for hepatology: validation in a naturally occurring canine model. Metabolomics 1:215-225.
63. Witkamp RF. 2005. Genomics and systems biology - how relevant are the developments to veterinary pharmacology, toxicology and therapeutics? J Vet Pharmacol Therapeut 28:235-245.